Search

Search Constraints

You searched for: Author/Creator Di Cosimo, Serena

Search Results

2. An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06). (December 2019)

4. Axillary Coverage by Whole Breast Irradiation in 1 to 2 Positive Sentinel Lymph Nodes in Breast Cancer Patients. Issue 4 (July 2016)

5. Body Mass Index and Clinical Benefit of Fulvestrant in Postmenopausal Women with Advanced Breast Cancer. Issue 4 (July 2016)

6. Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex. Issue 6 (21st June 2022)

8. Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial. Issue 6 (June 2021)

9. Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy. (4th August 2020)

10. COVID‐19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020. Issue 9 (8th July 2022)